RetinAI Discovery— 510(k) K211715
Substantially EquivalentRetinai Medical AG
FDA 510(k) clearance K211715 for RetinAI Discovery, Substantially Equivalent on 2022-04-28. Applicant: Retinai Medical AG. Device class: 2.
Clearance details
- Applicant
- Retinai Medical AG
- Product code
- Code NFJ
- Device class
- Class 2
- Regulation
- 21 CFR 892.2050
- Advisory panel
- Radiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Bern, CH
Recent devices under product code NFJ
view allData sourced from openFDA. This site is unofficial and independent of the FDA.